The effect of cyclosporin a on early and late stages of experimental lupus

Arthritis & Rheumatism

Volumn 35, Issue 11, 1992, Pages 1350-1355

  Blank, M ^a,b,c   Ben Bassat M ^a,b,c   Shoenfeld, Y ^a,b,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DNA ANTIBODY; DOUBLE STRANDED DNA; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMAL; ANTIBODY FORMATION; AUTOANTIBODIES; CYCLOSPORINE; FEMALE; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPH NODES; MICE; MICE, INBRED BALB C; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0026498819     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780351116     Document Type: Article

References (32)

1. Clinical manifestations of systemic lupus erythematosus: computer study of 520 cases
2. Lipopolysaccharides: from immune stimulation to autoimmunity
3. Detection of masked anti‐DNA antibodies in lupus sera by monoclonal anti‐idiotype
4. Anti‐DNA antibody idiotypes in systemic lupus erythematosus
5. Idiotypic cross‐reactions of monoclonal human lupus autoantibodies
6. Induction of SLE like disease in mice by a common anti‐DNA idiotype
7. Induction of SLE like disease in naive mice with a monoclonal anti DNA antibody derived from a patient with polymyositis carrying the 16/6 Id
8. The importance of the pathogenic 16/6 idiotype in the induction of SLE in naive mice
9. The role of anti‐idiotype antibodies in the induction of experimental SLE in mice
10. Induction of SLE in naive mice with T‐cell lines specific for human anti‐DNA antibody SA‐1 (16/6Id+) and for mouse tuberculosis antibody TB/68 (16/6Id+)
11. Modulation of induction of experimental SLE by Ts cells specific for anti‐DNA Id
12. The effect of the immunomodulator agent AS‐101 on interleukin‐2 production in SLE induced in mice by a pathogenic anti‐DNA antibody
13. The place of CsA in the treatment of connective tissue diseases
14. Down regulation of autoantibody levels by cyclosporine treatment in patients with uveitis
15. Cyclosporin A in the prevention and treatment of experimental autoimmune glomerulonephritis in the brown Norway rat
16. Polyspecificity of monoclonal lupus antibodies established by human hybridomas
17. Common lupus anti‐DNA idiotype in chronic liver diseases
18. Characterization and biological activities of an anti‐idiotype specific T cell line and its derived clones
19. A rapid method for the isolation of functional thymus derived murine lymphocytes
20. Treatment of experimental myasthenia gravis with cyclosporin A
21. Effect of cyclosporin A treatment on the production of antibody in insulin‐dependent (type 1) diabetic patients
22. Cyclosporin: speculation about its mechanism and action
23. Effect of cyclosporin A on T cell function in vitro: the mechanism of suppression of T cell proliferation depends on the nature of the T cell stimulus as well as the differentiation state of the responding T cell
24. Cyclosporin A inhibits T‐cell growth factor gene expression at the level of mRNA transcription
25. Effect of cyclosporin A on expression of IL‐2 and IL‐2 receptors in normal and multiple sclerosis patients
26. Prolongation of life in female NZB/NZW(F1) hybrid mice by cyclosporin‐A
27. Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS‐Zn) or cyclosporin‐A treated (NZB × NZW) F1 mice